000			02227 a2200637 4500
005			20250514051029.0
264		0	_c20030407
008			200304s 0 0 eng d
022			_a0006-4971
024	7		_a10.1182/blood-2002-05-1366 _2doi
040			_aNLM _beng _cNLM
100	1		_aLange, Thoralf
245	0	0	_aHigh levels of BAX, low levels of MRP-1, and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML. _h[electronic resource]
260			_bBlood _cMar 2003
300			_a2152-5 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntigens, CD34 _xanalysis
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aApoptosis _xgenetics
650	0	4	_aBenzamides
650	0	4	_aBlast Crisis _xdrug therapy
650	0	4	_aChemokines, CC _xgenetics
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aFemale
650	0	4	_aGene Expression
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aPlatelet Count
650	0	4	_aProto-Oncogene Proteins _xgenetics
650	0	4	_aProto-Oncogene Proteins c-bcl-2
650	0	4	_aPyrimidines _xtherapeutic use
650	0	4	_aRNA, Messenger _xanalysis
650	0	4	_aRemission Induction
650	0	4	_aStem Cell Transplantation
650	0	4	_aTransplantation, Homologous
650	0	4	_aTumor Cells, Cultured
650	0	4	_abcl-2-Associated X Protein
700	1		_aGünther, Christine
700	1		_aKöhler, Thomas
700	1		_aKrahl, Rainer
700	1		_aMusiol, Scarlet
700	1		_aLeiblein, Sabine
700	1		_aAl-Ali, Haifa-Kathrin
700	1		_avan Hoomissen, Iris
700	1		_aNiederwieser, Dietger
700	1		_aDeininger, Michael W N
773	0		_tBlood _gvol. 101 _gno. 6 _gp. 2152-5
856	4	0	_uhttps://doi.org/10.1182/blood-2002-05-1366 _zAvailable from publisher's website
999			_c12215193 _d12215193